Machine Learning and Drug Discovery

Yesterday, Recursion Pharmaceuticals announced that the Food and Drug Administration had cleared their investigational new drug application for a Phase 1 clinical trial in the treatment of cerebral cavernous malformation (CCM). While this is certainly good news for treating this rare genetic disease, it is also an important milestone in the use of machine learning […]

How AI is Transforming Drug Discovery

Bringing a new pharmaceutical drug to market takes about 12 years and can reach into the billions in R&D expenditures, industry leaders are now seeking more efficient methods of approaching this process and AI is emerging as a potential solution. The interest in AI-driven solutions for early stage drug discovery is growing steadily among biopharma […]